Table 1.
Baseline characteristics of study population.
| All | Preimplementation | Postimplementation | |
|---|---|---|---|
| Study sample | |||
| Participants, No. (% women) | 49 (45) | 23 (39) | 26 (50) |
| Women >65 y, No. (%) | 12 (25) | 4 (18) | 8 (31) |
| Women ≤65 y, No. (%) | 10 (20) | 5 (22) | 5 (19) |
| Men >65 y, No. (%) | 16 (33) | 7 (30) | 9 (34) |
| Men ≤65 y, No. (%) | 11 (22) | 7 (30) | 4 (16) |
| Men, age, y | |||
| Mean (SD) | 60 (14.4) | 59 (4.4) | 60 (14.9) |
| Range | 20–85 | 33–85 | 20–83 |
| Women, age, y | |||
| Mean (SD) | 59 (14.6) | 58 (15.2) | 61 (15.3) |
| Range | 35–82 | 35–72 | 41–82 |
| Medical history, No. (%) | |||
| Smoking | 20 (41) | 11 (48) | 9 (35) |
| Diabetes mellitus | 6 (12) | 4 (17) | 2 (8) |
| Hypertension | 22 (45) | 9 (39) | 13 (50) |
| Hyperlipidemia | 19 (39) | 9 (39) | 10 (38) |
| Family history | 25 (51) | 14 (61) | 11 (42) |
| Angina | 11 (22) | 5 (22) | 6 (23) |
| Myocardial infarction | 15 (31) | 9 (39) | 6 (21) |
| Previous PCI | 11 (22) | 7 (30) | 4 (15) |
| Previous CABG | 2 (4) | 1 (4) | 1 (4) |
| Heart failure | 0 | 0 | 0 |
| Cerebrovascular disease | 0 | 0 | 0 |
| Peripheral vascular disease | 1 (2) | 0 | 1 (4) |
| Length of stay, median (interquartile range), h | —∗ | 10.5 (8.2–12.3) | 3.4 (2.5–3.9) |
PCI, Percutaneous intervention; CABG, coronary artery bypass graft.
∗
Dash indicates value not calculated